Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Care > Global DNA Synthesis Market Outlook, In‑Depth Analysis & Forecast to 2031

Global DNA Synthesis Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Care

Published: 2025-08-08

Pages: 137 Pages

Report ld: 4921499

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global DNA Synthesis market is projected to grow from US$ 1401 million in 2024 to US$ 3410 million by 2031, at a CAGR of 13.6% (2025-2031), driven by critical product segments and diverse end‑use applications.

DNA synthesis is the natural or artificial creation of deoxyribonucleic acid (DNA) molecules. DNA is a macromolecule made up of nucleotide units, which are linked by covalent bonds and hydrogen bonds, in a repeating structure. DNA Synthesis refers to the process of artificially synthesizing DNA molecules under laboratory conditions. DNA synthesis is usually carried out through chemical synthesis methods, using known nucleotide monomers (A, T, C, G) in a specific order to gradually assemble the target DNA sequence in a test tube. DNA synthesis has a wide range of applications in the field of biotechnology, such as gene cloning, gene editing, synthetic biology and other fields. Scientific researchers and biotechnology companies can use DNA synthesis technology to design and synthesize specific DNA sequences for research on gene function, biomedical research and development, bioinformatics, etc. The development of DNA synthesis technology allows scientists to quickly and accurately synthesize DNA sequences of various lengths and complexities, providing powerful tools and support for life science research and biotechnology applications.

DNA Synthesis Market Size(US$)

M= millions and B=billions

Global key players of DNA Synthesis include Genescript, Thermo Fisher Scientific, IDT, Twist Bioscience, BBI, etc. The top five players hold a share about 53%. Asia-Pacific is the largest market, and has a share about 36%, followed by North America and Europe with share 35% and 26%, separately. In terms of product type, Oligonucleotide Synthesis is the largest segment, occupied for a share of 53%. In terms of application, Commercial has a share about 74 percent.

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global DNA Synthesis market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Report Metric
Details
Report Title
Global DNA Synthesis Market Outlook, In‑Depth Analysis & Forecast to 2031
Forecasted Market Size in 2031
US$ 3410 million
CAGR(2025-2031)
13.6%
Market Size Available for Years
2025-2031
Global DNA Synthesis Companies Covered
Genescript
Thermo Fisher Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Bioneer
Eton Bioscience
Synbio Technologies
Eurogentec
Global DNA Synthesis Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global DNA Synthesis Market, Segment by Type
Oligonucleotide Synthesis
Gene Synthesis
Global DNA Synthesis Market, Segment by Application
Commercial
Academic Research
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Defines the DNA Synthesis study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Table of Contents

1 Study Coverage
    1.1 Introduction to DNA Synthesis: Definition, Properties, and Key Attributes
    1.2 Market Segmentation by Type
        1.2.1 Global DNA Synthesis Market Size by Type, 2020 VS 2024 VS 2031
        1.2.2 Oligonucleotide Synthesis
        1.2.3 Gene Synthesis
    1.3 Market Segmentation by Application
        1.3.1 Global DNA Synthesis Market Size by Application, 2020 VS 2024 VS 2031
        1.3.2 Commercial
        1.3.3 Academic Research
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Executive Summary
    2.1 Global DNA Synthesis Revenue Estimates and Forecasts 2020-2031
    2.2 Global DNA Synthesis Revenue by Region
        2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
        2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
        2.2.3 Global Revenue Market Share by Region (2020-2031)
        2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players
    3.1 Global DNA Synthesis Player Revenue Rankings and Profitability
        3.1.1 Global Revenue (Value) by Players (2020-2025)
        3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
        3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
        3.1.4 Gross Margin by Top Player (2020 VS 2024)
    3.2 Global DNA Synthesis Companies Headquarters and Service Footprint
    3.3 Main Product Type Market Size by Players
        3.3.1 Oligonucleotide Synthesis Market Size by Players
        3.3.2 Gene Synthesis Market Size by Players
    3.4 Global DNA Synthesis Market Concentration and Dynamics
        3.4.1 Global Market Concentration (CR5 and HHI)
        3.4.2 Entrant/Exit Impact Analysis
        3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis
    4.1 Global DNA Synthesis Revenue Trends by Type
        4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
        4.1.2 Global Revenue Market Share by Type (2020-2031)
    4.2 Key Product Attributes and Differentiation
    4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
        4.3.1 High-Growth Niches and Adoption Drivers
        4.3.2 Profitability Hotspots and Cost Drivers
        4.3.3 Substitution Threats

5 Global Downstream Application Analysis
    5.1 Global DNA Synthesis Revenue by Application
        5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
        5.1.2 Revenue Market Share by Application (2020-2031)
        5.1.3 High-Growth Application Identification
        5.1.4 Emerging Application Case Studies
    5.2 Downstream Customer Analysis
        5.2.1 Top Customers by Region
        5.2.2 Top Customers by Application

6 North America
    6.1 North America Market Size (2020-2031)
    6.2 North America Key Players Revenue in 2024
    6.3 North America DNA Synthesis Market Size by Type (2020-2031)
    6.4 North America DNA Synthesis Market Size by Application (2020-2031)
    6.5 North America Growth Accelerators and Market Barriers
    6.6 North America DNA Synthesis Market Size by Country
        6.6.1 North America Revenue Trends by Country
        6.6.2 US
        6.6.3 Canada
        6.6.4 Mexico

7 Europe
    7.1 Europe Market Size (2020-2031)
    7.2 Europe Key Players Revenue in 2024
    7.3 Europe DNA Synthesis Market Size by Type (2020-2031)
    7.4 Europe DNA Synthesis Market Size by Application (2020-2031)
    7.5 Europe Growth Accelerators and Market Barriers
    7.6 Europe DNA Synthesis Market Size by Country
        7.6.1 Europe Revenue Trends by Country
        7.6.2 Germany
        7.6.3 France
        7.6.4 U.K.
        7.6.5 Italy
        7.6.6 Netherlands

8 Asia-Pacific
    8.1 Asia-Pacific Market Size (2020-2031)
    8.2 Asia-Pacific Key Players Revenue in 2024
    8.3 Asia-Pacific DNA Synthesis Market Size by Type (2020-2031)
    8.4 Asia-Pacific DNA Synthesis Market Size by Application (2020-2031)
    8.5 Asia-Pacific Growth Accelerators and Market Barriers
    8.6 Asia-Pacific DNA Synthesis Market Size by Region
        8.6.1 Asia-Pacific Revenue Trends by Region
    8.7 China
    8.8 Japan
    8.9 South Korea
    8.10 Australia
    8.11 India
    8.12 Southeast Asia
        8.12.1 Indonesia
        8.12.2 Vietnam
        8.12.3 Malaysia
        8.12.4 Philippines
        8.12.5 Singapore

9 Central and South America
    9.1 Central and South America Market Size (2020-2031)
    9.2 Central and South America Key Players Revenue in 2024
    9.3 Central and South America DNA Synthesis Market Size by Type (2020-2031)
    9.4 Central and South America DNA Synthesis Market Size by Application (2020-2031)
    9.5 Central and South America Investment Opportunities and Key Challenges
    9.6 Central and South America DNA Synthesis Market Size by Country
        9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
        9.6.2 Brazil
        9.6.3 Argentina

10 Middle East and Africa
    10.1 Middle East and Africa Market Size (2020-2031)
    10.2 Middle East and Africa Key Players Revenue in 2024
    10.3 Middle East and Africa DNA Synthesis Market Size by Type (2020-2031)
    10.4 Middle East and Africa DNA Synthesis Market Size by Application (2020-2031)
    10.5 Middle East and Africa Investment Opportunities and Key Challenges
    10.6 Middle East and Africa DNA Synthesis Market Size by Country
        10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
        10.6.2 GCC Countries
        10.6.3 Israel
        10.6.4 Egypt
        10.6.5 South Africa

11 Corporate Profile
    11.1 Genescript
        11.1.1 Genescript Corporation Information
        11.1.2 Genescript Business Overview
        11.1.3 Genescript DNA Synthesis Product Features and Attributes
        11.1.4 Genescript DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.1.5 Genescript DNA Synthesis Revenue by Product in 2024
        11.1.6 Genescript DNA Synthesis Revenue by Application in 2024
        11.1.7 Genescript DNA Synthesis Revenue by Geographic Area in 2024
        11.1.8 Genescript DNA Synthesis SWOT Analysis
        11.1.9 Genescript Recent Developments
    11.2 Thermo Fisher Scientific
        11.2.1 Thermo Fisher Scientific Corporation Information
        11.2.2 Thermo Fisher Scientific Business Overview
        11.2.3 Thermo Fisher Scientific DNA Synthesis Product Features and Attributes
        11.2.4 Thermo Fisher Scientific DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.2.5 Thermo Fisher Scientific DNA Synthesis Revenue by Product in 2024
        11.2.6 Thermo Fisher Scientific DNA Synthesis Revenue by Application in 2024
        11.2.7 Thermo Fisher Scientific DNA Synthesis Revenue by Geographic Area in 2024
        11.2.8 Thermo Fisher Scientific DNA Synthesis SWOT Analysis
        11.2.9 Thermo Fisher Scientific Recent Developments
    11.3 IDT
        11.3.1 IDT Corporation Information
        11.3.2 IDT Business Overview
        11.3.3 IDT DNA Synthesis Product Features and Attributes
        11.3.4 IDT DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.3.5 IDT DNA Synthesis Revenue by Product in 2024
        11.3.6 IDT DNA Synthesis Revenue by Application in 2024
        11.3.7 IDT DNA Synthesis Revenue by Geographic Area in 2024
        11.3.8 IDT DNA Synthesis SWOT Analysis
        11.3.9 IDT Recent Developments
    11.4 Eurofins Genomics
        11.4.1 Eurofins Genomics Corporation Information
        11.4.2 Eurofins Genomics Business Overview
        11.4.3 Eurofins Genomics DNA Synthesis Product Features and Attributes
        11.4.4 Eurofins Genomics DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.4.5 Eurofins Genomics DNA Synthesis Revenue by Product in 2024
        11.4.6 Eurofins Genomics DNA Synthesis Revenue by Application in 2024
        11.4.7 Eurofins Genomics DNA Synthesis Revenue by Geographic Area in 2024
        11.4.8 Eurofins Genomics DNA Synthesis SWOT Analysis
        11.4.9 Eurofins Genomics Recent Developments
    11.5 DNA 2.0 (ATUM)
        11.5.1 DNA 2.0 (ATUM) Corporation Information
        11.5.2 DNA 2.0 (ATUM) Business Overview
        11.5.3 DNA 2.0 (ATUM) DNA Synthesis Product Features and Attributes
        11.5.4 DNA 2.0 (ATUM) DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.5.5 DNA 2.0 (ATUM) DNA Synthesis Revenue by Product in 2024
        11.5.6 DNA 2.0 (ATUM) DNA Synthesis Revenue by Application in 2024
        11.5.7 DNA 2.0 (ATUM) DNA Synthesis Revenue by Geographic Area in 2024
        11.5.8 DNA 2.0 (ATUM) DNA Synthesis SWOT Analysis
        11.5.9 DNA 2.0 (ATUM) Recent Developments
    11.6 BBI
        11.6.1 BBI Corporation Information
        11.6.2 BBI Business Overview
        11.6.3 BBI DNA Synthesis Product Features and Attributes
        11.6.4 BBI DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.6.5 BBI Recent Developments
    11.7 Azenta Life Sciences
        11.7.1 Azenta Life Sciences Corporation Information
        11.7.2 Azenta Life Sciences Business Overview
        11.7.3 Azenta Life Sciences DNA Synthesis Product Features and Attributes
        11.7.4 Azenta Life Sciences DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.7.5 Azenta Life Sciences Recent Developments
    11.8 SBS Genetech
        11.8.1 SBS Genetech Corporation Information
        11.8.2 SBS Genetech Business Overview
        11.8.3 SBS Genetech DNA Synthesis Product Features and Attributes
        11.8.4 SBS Genetech DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.8.5 SBS Genetech Recent Developments
    11.9 Bio Basic
        11.9.1 Bio Basic Corporation Information
        11.9.2 Bio Basic Business Overview
        11.9.3 Bio Basic DNA Synthesis Product Features and Attributes
        11.9.4 Bio Basic DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.9.5 Bio Basic Recent Developments
    11.10 Twist Bioscience
        11.10.1 Twist Bioscience Corporation Information
        11.10.2 Twist Bioscience Business Overview
        11.10.3 Twist Bioscience DNA Synthesis Product Features and Attributes
        11.10.4 Twist Bioscience DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.10.5 Company Ten Recent Developments
    11.11 OriGene
        11.11.1 OriGene Corporation Information
        11.11.2 OriGene Business Overview
        11.11.3 OriGene DNA Synthesis Product Features and Attributes
        11.11.4 OriGene DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.11.5 OriGene Recent Developments
    11.12 Bioneer
        11.12.1 Bioneer Corporation Information
        11.12.2 Bioneer Business Overview
        11.12.3 Bioneer DNA Synthesis Product Features and Attributes
        11.12.4 Bioneer DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.12.5 Bioneer Recent Developments
    11.13 Eton Bioscience
        11.13.1 Eton Bioscience Corporation Information
        11.13.2 Eton Bioscience Business Overview
        11.13.3 Eton Bioscience DNA Synthesis Product Features and Attributes
        11.13.4 Eton Bioscience DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.13.5 Eton Bioscience Recent Developments
    11.14 Synbio Technologies
        11.14.1 Synbio Technologies Corporation Information
        11.14.2 Synbio Technologies Business Overview
        11.14.3 Synbio Technologies DNA Synthesis Product Features and Attributes
        11.14.4 Synbio Technologies DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.14.5 Synbio Technologies Recent Developments
    11.15 Eurogentec
        11.15.1 Eurogentec Corporation Information
        11.15.2 Eurogentec Business Overview
        11.15.3 Eurogentec DNA Synthesis Product Features and Attributes
        11.15.4 Eurogentec DNA Synthesis Revenue and Gross Margin (2020-2025)
        11.15.5 Eurogentec Recent Developments

12 DNA SynthesisIndustry Chain Analysis
    12.1 DNA Synthesis Industry Chain
    12.2 Upstream Analysis
        12.2.1 Upstream Key Suppliers
    12.3 Middlestream Analysis
    12.4 Downstream Sales Model and Distribution Networks
        12.4.1 Sales Channels
        12.4.2 Distributors

13 DNA Synthesis Market Dynamics
    13.1 Industry Trends and Evolution
    13.2 Market Growth Drivers and Emerging Opportunities
    13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global DNA Synthesis Study

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details

Table of Figures

List of Tables
 Table 1. Global DNA Synthesis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global DNA Synthesis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global DNA Synthesis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global DNA Synthesis Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global DNA Synthesis Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global DNA Synthesis Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global DNA Synthesis Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global DNA Synthesis by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Synthesis as of 2024)
 Table 11. Global DNA Synthesis Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global DNA Synthesis Companies Headquarters
 Table 13. Global DNA Synthesis Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global DNA Synthesis Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global DNA Synthesis Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global DNA Synthesis Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global DNA Synthesis Revenue by Application (2026-2031) & (US$ Million)
 Table 21. DNA Synthesis High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America DNA Synthesis Growth Accelerators and Market Barriers
 Table 25. North America DNA Synthesis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe DNA Synthesis Growth Accelerators and Market Barriers
 Table 27. Europe DNA Synthesis Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific DNA Synthesis Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific DNA Synthesis Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America DNA Synthesis Investment Opportunities and Key Challenges
 Table 31. Central and South America DNA Synthesis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa DNA Synthesis Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa DNA Synthesis Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Genescript Corporation Information
 Table 35. Genescript Description and Major Businesses
 Table 36. Genescript Product Features and Attributes
 Table 37. Genescript Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Genescript Revenue Proportion by Product in 2024
 Table 39. Genescript Revenue Proportion by Application in 2024
 Table 40. Genescript Revenue Proportion by Geographic Area in 2024
 Table 41. Genescript DNA Synthesis SWOT Analysis
 Table 42. Genescript Recent Developments
 Table 43. Thermo Fisher Scientific Corporation Information
 Table 44. Thermo Fisher Scientific Description and Major Businesses
 Table 45. Thermo Fisher Scientific Product Features and Attributes
 Table 46. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Thermo Fisher Scientific Revenue Proportion by Product in 2024
 Table 48. Thermo Fisher Scientific Revenue Proportion by Application in 2024
 Table 49. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
 Table 50. Thermo Fisher Scientific DNA Synthesis SWOT Analysis
 Table 51. Thermo Fisher Scientific Recent Developments
 Table 52. IDT Corporation Information
 Table 53. IDT Description and Major Businesses
 Table 54. IDT Product Features and Attributes
 Table 55. IDT Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. IDT Revenue Proportion by Product in 2024
 Table 57. IDT Revenue Proportion by Application in 2024
 Table 58. IDT Revenue Proportion by Geographic Area in 2024
 Table 59. IDT DNA Synthesis SWOT Analysis
 Table 60. IDT Recent Developments
 Table 61. Eurofins Genomics Corporation Information
 Table 62. Eurofins Genomics Description and Major Businesses
 Table 63. Eurofins Genomics Product Features and Attributes
 Table 64. Eurofins Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Eurofins Genomics Revenue Proportion by Product in 2024
 Table 66. Eurofins Genomics Revenue Proportion by Application in 2024
 Table 67. Eurofins Genomics Revenue Proportion by Geographic Area in 2024
 Table 68. Eurofins Genomics DNA Synthesis SWOT Analysis
 Table 69. Eurofins Genomics Recent Developments
 Table 70. DNA 2.0 (ATUM) Corporation Information
 Table 71. DNA 2.0 (ATUM) Description and Major Businesses
 Table 72. DNA 2.0 (ATUM) Product Features and Attributes
 Table 73. DNA 2.0 (ATUM) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. DNA 2.0 (ATUM) Revenue Proportion by Product in 2024
 Table 75. DNA 2.0 (ATUM) Revenue Proportion by Application in 2024
 Table 76. DNA 2.0 (ATUM) Revenue Proportion by Geographic Area in 2024
 Table 77. DNA 2.0 (ATUM) DNA Synthesis SWOT Analysis
 Table 78. DNA 2.0 (ATUM) Recent Developments
 Table 79. BBI Corporation Information
 Table 80. BBI Description and Major Businesses
 Table 81. BBI Product Features and Attributes
 Table 82. BBI Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. BBI Recent Developments
 Table 84. Azenta Life Sciences Corporation Information
 Table 85. Azenta Life Sciences Description and Major Businesses
 Table 86. Azenta Life Sciences Product Features and Attributes
 Table 87. Azenta Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Azenta Life Sciences Recent Developments
 Table 89. SBS Genetech Corporation Information
 Table 90. SBS Genetech Description and Major Businesses
 Table 91. SBS Genetech Product Features and Attributes
 Table 92. SBS Genetech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. SBS Genetech Recent Developments
 Table 94. Bio Basic Corporation Information
 Table 95. Bio Basic Description and Major Businesses
 Table 96. Bio Basic Product Features and Attributes
 Table 97. Bio Basic Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Bio Basic Recent Developments
 Table 99. Twist Bioscience Corporation Information
 Table 100. Twist Bioscience Description and Major Businesses
 Table 101. Twist Bioscience Product Features and Attributes
 Table 102. Twist Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Twist Bioscience Recent Developments
 Table 104. OriGene Corporation Information
 Table 105. OriGene Description and Major Businesses
 Table 106. OriGene Product Features and Attributes
 Table 107. OriGene Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. OriGene Recent Developments
 Table 109. Bioneer Corporation Information
 Table 110. Bioneer Description and Major Businesses
 Table 111. Bioneer Product Features and Attributes
 Table 112. Bioneer Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Bioneer Recent Developments
 Table 114. Eton Bioscience Corporation Information
 Table 115. Eton Bioscience Description and Major Businesses
 Table 116. Eton Bioscience Product Features and Attributes
 Table 117. Eton Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Eton Bioscience Recent Developments
 Table 119. Synbio Technologies Corporation Information
 Table 120. Synbio Technologies Description and Major Businesses
 Table 121. Synbio Technologies Product Features and Attributes
 Table 122. Synbio Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Synbio Technologies Recent Developments
 Table 124. Eurogentec Corporation Information
 Table 125. Eurogentec Description and Major Businesses
 Table 126. Eurogentec Product Features and Attributes
 Table 127. Eurogentec Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Eurogentec Recent Developments
 Table 129. Raw Materials Key Suppliers
 Table 130. Distributors List
 Table 131. Market Trends and Market Evolution
 Table 132. Market Drivers and Opportunities
 Table 133. Market Challenges, Risks, and Restraints
 Table 134. Research Programs/Design for This Report
 Table 135. Key Data Information from Secondary Sources
 Table 136. Key Data Information from Primary Sources


List of Figures
 Figure 1. DNA Synthesis Product Picture
 Figure 2. Global DNA Synthesis Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Oligonucleotide Synthesis Product Picture
 Figure 4. Gene Synthesis Product Picture
 Figure 5. Global DNA Synthesis Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Commercial
 Figure 7. Academic Research
 Figure 8. DNA Synthesis Report Years Considered
 Figure 9. Global DNA Synthesis Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 11. Global DNA Synthesis Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global DNA Synthesis Revenue Market Share by Region (2020-2031)
 Figure 13. Global DNA Synthesis Revenue Market Share Ranking (2024)
 Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 15. Oligonucleotide Synthesis Revenue Market Share by Player in 2024
 Figure 16. Gene Synthesis Revenue Market Share by Player in 2024
 Figure 17. Global DNA Synthesis Revenue Market Share by Type (2020-2031)
 Figure 18. Global DNA Synthesis Revenue Market Share by Application (2020-2031)
 Figure 19. North America DNA Synthesis Revenue YoY (2020-2031) & (US$ Million)
 Figure 20. North America Top 5 Players DNA Synthesis Revenue (US$ Million) in 2024
 Figure 21. North America DNA Synthesis Revenue (US$ Million) by Type (2020 - 2031)
 Figure 22. North America DNA Synthesis Revenue (US$ Million) by Application (2020-2031)
 Figure 23. US DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 24. Canada DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 25. Mexico DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 26. Europe DNA Synthesis Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Europe Top 5 Players DNA Synthesis Revenue (US$ Million) in 2024
 Figure 28. Europe DNA Synthesis Revenue (US$ Million) by Type (2020-2031)
 Figure 29. Europe DNA Synthesis Revenue (US$ Million) by Application (2020-2031)
 Figure 30. Germany DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 31. France DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 32. U.K. DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 33. Italy DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 34. Netherlands DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific DNA Synthesis Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Top 8 Players DNA Synthesis Revenue (US$ Million) in 2024
 Figure 37. Asia-Pacific DNA Synthesis Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Asia-Pacific DNA Synthesis Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Indonesia DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 40. Japan DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 41. South Korea DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 42. Australia DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 43. India DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 44. Indonesia DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 45. Vietnam DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 46. Malaysia DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 47. Philippines DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 48. Singapore DNA Synthesis Revenue (2020-2031) & (US$ Million)
 Figure 49. Central and South America DNA Synthesis Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Central and South America Top 5 Players DNA Synthesis Revenue (US$ Million) in 2024
 Figure 51. Central and South America DNA Synthesis Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Central and South America DNA Synthesis Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Brazil DNA Synthesis Revenue (2020-2025) & (US$ Million)
 Figure 54. Argentina DNA Synthesis Revenue (2020-2025) & (US$ Million)
 Figure 55. Middle East and Africa DNA Synthesis Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Top 5 Players DNA Synthesis Revenue (US$ Million) in 2024
 Figure 57. South America DNA Synthesis Revenue (US$ Million) by Type (2020-2031)
 Figure 58. Middle East and Africa DNA Synthesis Revenue (US$ Million) by Application (2020-2031)
 Figure 59. GCC Countries DNA Synthesis Revenue (2020-2025) & (US$ Million)
 Figure 60. Israel DNA Synthesis Revenue (2020-2025) & (US$ Million)
 Figure 61. Egypt DNA Synthesis Revenue (2020-2025) & (US$ Million)
 Figure 62. South Africa DNA Synthesis Revenue (2020-2025) & (US$ Million)
 Figure 63. DNA Synthesis Industry Chain Mapping
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed